VHL, Jade-1 and protein stability in renal cancer
VHL, Jade-1 and protein stability in renal cancer
批准号:
6686928
负责人:
HERBERT TOD COHEN
金额:
$32.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2008-06-30
关键词:
DNA binding protein apoptosis athymic mouse chemical stability chromatin clinical research gene expression genetic regulation human subject human tissue immunoprecipitation kidney neoplasms ligase point mutation posttranslational modifications protein binding protein degradation protein localization protein protein interaction protein structure function transcription factor tumor suppressor proteins ubiquitin
中文摘要
修订摘要:肾癌是一种破坏性的恶性肿瘤,对
药物治疗。VHL肿瘤抑制基因在大多数成人肾脏中发生突变
癌症。然而,VHL抑制肿瘤的机制尚不清楚。使用
寻找肾脏中重要的VHL相互作用蛋白的定向方法
癌症,我们的实验室已经鉴定出JADE-1(细胞凋亡和
上皮细胞分化)作为一种特别强的VHL相互作用因子。
JADE-1是一种新的富肾、害虫和植物同源结构域蛋白,是一种
是一个新的蛋白质家族的成员。VHL稳定Jade-1蛋白,Jade-1是一种
新的VHL功能。此外,我们现在已经表明,JADE-1稳定化是
VHL突变依赖,伴有非肾癌导致的VHL错义突变
能够像野生型VHL一样稳定Jade-1。Jade-1稳定器是
因此,VHL活动第一次显示出与
肾癌的风险,这表明它与疾病有关。此外,
VHL对JADE-1的稳定具有高度的特异性,因为它还没有
与已知或潜在的VHL合作伙伴进行观察。我们已经确立了
VHL-Jade-1关系的真实性也是令人信服的证据
作为玉石一号,S具有令人信服的生物学意义。我们提出以下建议
目标:
1.VHL-JADE-1蛋白-蛋白相互作用及JADE-1的表达
肾癌组织
2.VHL依赖的JADE-1的稳定和修饰
3.Jade-1在VHL诱导细胞凋亡及调控中的作用
英文摘要
Revised Abstract: Renal cancer is a devastating malignancy that is highly resistant to
medical therapy. The VHL tumor suppressor is mutated in most adult renal
cancers. Yet, the mechanism of VHL tumor suppression is not known. Using a
directed approach to find VHL-interacting proteins important in renal
cancer, our laboratory has identified Jade-1 (gene for Apoptosis and
Differentiation in Epithelia) as a particularly strong VHL interactor.
Jade-1, a novel,kidney-enriched, PEST and plant homeodomain protein, is a
member of a new protein family. VHL stabilizes Jade-1 protein, which is a
new VHL function. Moreover, we have now shown that Jade-1 stabilization is
VHL mutation-dependent, with non-renal cancer-causing VHL missense mutations
able to stabilize Jade-1 like wild-type VHL. Jade-1 stabilization is
therefore the first VHL activity to show substantial correlation with
renal cancer risk, suggesting it has a disease relationship. Moreover,
stabilization of Jade-1 by VHL is highly specific, as it has not been
observed with known or potential VHL partners. We have established
convincing evidence of the VHL-Jade-1 relationship's authenticity as well
as Jade-1's compelling biological significance. We propose the following
Aims:
1. The VHL-Jade-1 protein-protein interaction, and Jade-1 expression in
renal cancer tissue
2. VHL-dependent Jade-1 stabilization and modification
3. Examination of the role of Jade-1 in apoptosis and modulation by VHL
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Jade-1 in cystic renal disease
-
批准号:6861859
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7049325
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:6768201
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7379930
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
Jade-1 in cystic renal disease
-
批准号:7234711
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2004
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:2733434
-
项目类别:
-
资助金额:$31.63万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:7227198
-
项目类别:
-
资助金额:$30.53万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8585027
-
项目类别:
-
资助金额:$31.06万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8196861
-
项目类别:
-
资助金额:$32.02万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:6173732
-
项目类别:
-
资助金额:$29.27万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6919315
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8578133
-
项目类别:
-
资助金额:$6.48万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:7999259
-
项目类别:
-
资助金额:$32.02万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8787179
-
项目类别:
-
资助金额:$6.69万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL
-
批准号:6376964
-
项目类别:
-
资助金额:$33.55万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8527928
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:8387038
-
项目类别:
-
资助金额:$30.1万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:7084646
-
项目类别:
-
资助金额:$31.44万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
VHL, Jade-1 and protein stability in renal cancer
-
批准号:6777002
-
项目类别:
-
资助金额:$32.2万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
The pVHL/Jade-1/beta-catenin axis in renal cancer
-
批准号:7782104
-
项目类别:
-
资助金额:$33.01万
-
财政年份:1999
-
负责人:HERBERT TOD COHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: